BackCitius Oncology Overview
Citius Oncology Inc.

Citius Oncology Discounted Cash Flow

DCF Analysis for CTOR.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.00

Current Fair Value

$0.00
99.7% Downside

Overvalued by 99.7% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading